Abstract
The pharmacokinetics of delta 9-tetrahydrocannabinol (delta 9-THC) has been studied in rabbits under conditions of single or multiple administration. Measurement of the drug was by a sensitive GC/MS technique using metastable ion monitoring and capable of measuring 0.005 ng/ml of the drug in plasma. This method enabled measurements of the drug to be made for 8-10 days after a single iv dose of 1 mg/kg of delta 9-THC and for 26 days following treatment for 22 days with the same dose. Plasma concentration-time data were analyzed by least squares nonlinear regression with the program NONLIN and terminal half-lives in the range 30-66 hr [mean 47.1 +/- 3.5 (SE), n = 8] were found after acute drug treatment. These increased to 74.6 +/- 1.7 hr (n = 4) after an 8-day treatment and to 83.0 hr after the 22-day treatment. Plasma clearance values were high, but the large amount of drug sequestered in tissues, reflected by large volumes of distribution, was the main determinant of terminal half-life. Measurements of the drug in several tissues indicated that fat was the major site of sequestration. The relative concentrations of delta 9-THC in the various tissues were similar to those observed for other lipophilic compounds, suggesting that distribution of delta 9-THC is governed by its physicochemical properties and not by any active transport process or specific barriers.
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|